Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience
CAP TODAY does not endorse any of the products or services named within. The roundtable is made possible by a special educational grant from Tosoh Bioscience Inc.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.
Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from OncoLens and Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The roundtable is made possible by a special educational grant from Pillar Biosciences.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.
Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Illumina.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Aug. 8, 2014—In this white paper, SeraCare Life Sciences notes that “every laboratory must ask what are the appropriate [quality control] goals and what are the most cost-effective ways to achieve these goals.” The paper reviews how often to run controls, how many replicates to run, and covers useful ways to plot assay QC in real time. Read.
Aug. 8, 2014—Randy German, MT(ASCP), blood bank and laboratory quality manager at Hoag Memorial Hospital, will share best practices for nonconforming event and blood product deviation reporting and investigation in a 50-minute webinar hosted by Nouvation, maker of occurrence-tracking software. German will review regulatory requirements, discuss what should be reported, and explain effective root-cause analysis in a blame-free culture. To register, fill out this contact form and note your interest in the Sept. 24, 2014, webinar in the question field
Aug. 6, 2014—A two-day online conference Aug. 20-21 will cover a wide range of topic in genetics and genomics, such as RNAi, next-generation sequencing, genotyping, and molecular diagnostics. The meeting—sponsored by Thermo Fisher Scientific, Beckman Coulter, Roche, and other firms—will feature interactive, live streaming video sessions and a virtual exhibit floor. Faculty includes experts from MD Anderson Cancer Center, Dartmouth, and Stanford. Free CME, CE, and CEU credits are available. Register.
July 10, 2014—Instrumentation Laboratory is presenting two, hour-long educational sessions at the AACC’s Annual Meeting and Clinical Lab Expo. The first will feature Ted E. Warkentin, MD, and Pau Bruguera, PhD, on clinical and laboratory aspects of heparin-induced thrombocytopenia diagnostics (register). In the other workshop, Sharon Ehrmeyer, PhD, MT(ASCP), will talk about how to develop and implement individualized quality-control plans in POC testing (register).
June 2014—The Food and Drug Administration on April 24 approved use of the Roche Cobas HPV test as a primary standalone screen for cervical cancer in women 25 and older. CAP TODAY writer William Check, PhD, asked questions of Thomas S. Lorey, MD, medical director, TPMG Regional Reference Laboratory, Kaiser Permanente Northern California. Their questions and answers follow. For a discussion of the ATHENA data on which the FDA based its decision, see Dr. Check’s June story “Data spark new directions in cervical cancer.”
May 12, 2014—Sylvia L. Asa, MD, PhD, reviews her role in forming a pathology “dream team” at Toronto’s University Health Network to ensure the right pathologist sees the right specimen at the right time. Flexible staffing models, hospital partnerships, and technology adoption are key to innovating in diagnostics, she says. Watch the video.
May 7, 2014—CAP members should now complete the 2014 CAP Practice Characteristics Survey (PCS), if you haven’t done so already. Results from the survey will help the College set advocacy priorities and outline regional market pressures and environmental changes impacting the individual pathologist. After completing the survey, participants will be entered in a weekly prize drawing.
An expert on the diagnostic evaluation and management of hemorrhagic and thromboembolic disorders will explain one way to optimize efficiency and outcomes with regard to laboratory monitoring of heparin therapies. The April 30 event is free. Register.
An Applied Spectral Imaging April 8 webinar explains the company’s product, Tissue Match, in which a pathologist uses a brightfield H&E or IHC review to mark the exact region of interest for FISH scanning. The FISH technician then knows the exact area to analyze. Read more on how to register.
A review paper released by cancer diagnostics firm Dako aims to provide prostate pathologists a comprehensive reference on the use of various prostate markers, as well as their limitations. Download the paper.
